DFSVX
Price
$62.16
Change
-$0.03 (-0.05%)
Updated
Jul 31 closing price
Net Assets
19.45B
NSVAX
Price
$15.85
Change
+$0.03 (+0.19%)
Updated
Jul 31 closing price
Net Assets
919.05M
Interact to see
Advertisement

DFSVX vs NSVAX

DFSVX vs NSVAX Comparison Chart in %
View a ticker or compare two or three
VS
DFSVX vs. NSVAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DFSVX is a StrongBuy and NSVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
DFSVX has more cash in the bank: 19.5B vs. NSVAX (919M). DFSVX pays higher dividends than NSVAX: DFSVX (1.50) vs NSVAX (0.64). DFSVX was incepted earlier than NSVAX: DFSVX (33 years) vs NSVAX (24 years). NSVAX (1.12) is less costly to investors than DFSVX (0.31). NSVAX is a more actively managed with annual turnover of: 115.00 vs. DFSVX (7.00). DFSVX has a lower initial minimum investment than NSVAX: DFSVX (0) vs NSVAX (2000). DFSVX annual gain was more profitable for investors over the last year : 34.39 vs. NSVAX (18.78). DFSVX return over 5 years is better than : 50.66 vs. NSVAX (-14.73).
DFSVXNSVAXDFSVX / NSVAX
Total Expense Ratio0.310.9533%
Annual Report Gross Expense Ratio0.311.1228%
Fund Existence33 years24 years-
Gain YTD21.33618.727114%
Front LoadN/AN/A-
Min. Initial Investment02000-
Min. Initial Investment IRAN/AN/A-
Net Assets19.5B919M2,122%
Annual Yield % from dividends1.500.64233%
Returns for 1 year34.3918.78183%
Returns for 3 years50.37-2.59-1,946%
Returns for 5 years50.66-14.73-344%
Returns for 10 years107.715.182,080%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HSVRX54.680.40
+0.74%
Harbor Small Cap Value Admin
DESSX29.040.10
+0.35%
DWS Enhanced Core Equity S
AGIRX22.310.05
+0.22%
Alger Mid Cap Growth Institutional R
IAXSX9.86-0.03
-0.30%
VY® T. Rowe Price Divers Mid Cap Gr S
THISX89.95-1.09
-1.20%
T. Rowe Price Health Sciences I